@Glamsham Model |
Peter Johann is a managing general partner at NGN Capital, a venture capital firm that invests in private and public biotech and medical device companies. In this exclusive interview with The Life Sciences Report, Johann discusses pharmaceutical and medical device companies in his portfolio, pointing out opportunities for venture capitalists that are also potential boons for private investors.
#PRIVATEEQUITY #VENTURECAPITAL, #HEDGEFUNDS, #INVESTMENTBANKING & a few fun things as well. Check US OUT: http://on.fb.me/vch6FQ http://linkd.in/oiB29lhttp://on.fb.me/sdaWqc http://bit.ly/uhH9hQ http://bit.ly/trKLuj http://goo.gl/Q376nkeywords: #PrivateEquity, #HedgeFunds, #VentureCapital, #InvestmentBanking, #AlernativeAssets, #CapitalMarkets, #MergersAndAcquisitions, #WallStreet, #IPO #ResilientMediaEntertainment, #IPO, @Resilient_Ent, #Film, #Music, #VideoGaming, #Media, #Fashion, #TV, #Technology #JointVentures #FaceBook #Magazines #PublicRelations #Radio #WealthManagementtags: +PrivateEquity, +HedgeFunds, +VentureCapital, +InvestmentBanking, +AlernativeAssets, +CapitalMarkets, +MergersAndAcquisitions, +WallStreet, +IPO +ResilientMediaEntertainment, +IPO, +@Resilient_Ent, +Film, +Music, +VideoGaming, +Media, +Fashion, +TV, +Technology +JointVentures +FaceBook, +Magazines +PublicRelations,+Radio, +WealthManagement
No comments:
Post a Comment
WHAT SAY YOU?